Low Salicylate Diet in Aspirin Exacerbated Respiratory Disease
NCT01540032 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2012-02-28
Summary
The purpose of this study is to determine whether a low salicylate diet will improve the quality of life of patients with Aspirin Exacerbated Respiratory Disease (AERD).
Conditions
- Aspirin Exacerbated Respiratory Disease
- Samter's Triad
Interventions
- BEHAVIORAL
-
Low salicylate diet
Patients will avoid foods from the 'high salicylate' group completely. They can eat foods from the 'low salicylate' group freely and just eat foods from the medium group occasionally, and not in large amounts.
- BEHAVIORAL
-
Normal diet
Patients will eat their usual diet.
Sponsors & Collaborators
-
Hamilton Health Sciences Corporation
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-02-29
- Primary Completion
- 2013-02-28
- Completion
- 2013-02-28
Countries
- Canada
Study Locations
More Related Trials
-
Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study
NCT01534026 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Resistance in Coronary Artery Disease
NCT00753935 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of Dupilumab on Aspirin Intolerance
NCT04442256 ·Status: UNKNOWN ·Phase: PHASE4
-
Personalizing Aspirin Therapy in Peripheral Arterial Disease Patients
NCT04269863 ·Status: UNKNOWN ·Phase: NA
-
Compliance in the Physicians' Health Study
NCT00005404 ·Status: COMPLETED
-
The Antiaggregation Monitoring (TAM) Registry
NCT01329224 ·Status: COMPLETED
-
Mechanism Based Resistance to Aspirin
NCT00948987 ·Status: COMPLETED ·Phase: PHASE1
-
Low Dose Aspirin Studied With the AggreGuide
NCT01603966 ·Status: COMPLETED
-
Upper GI Symptoms In Patients Receiving Acetylsalicylic Acid/NSAIDs - NSAIDs Wave 2
NCT00691743 ·Status: COMPLETED
-
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes
NCT05105919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting
NCT01276691 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension
NCT00449618 ·Status: TERMINATED ·Phase: PHASE4
-
Aspirin Resistance in OSA Patients
NCT03930875 ·Status: COMPLETED
-
Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
NCT01709994 ·Status: UNKNOWN ·Phase: PHASE3
-
Acute Effect of Nitrate From Natural Dietary Sources on Arterial Stiffness and Blood Pressures in Healthy Individuals
NCT01604993 ·Status: COMPLETED ·Phase: PHASE2
-
Physiopathology of Rapid Aspirin Desensitization
NCT01118546 ·Status: COMPLETED
-
Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)
NCT04261582 ·Status: SUSPENDED
-
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II
NCT05702463 ·Status: RECRUITING ·Phase: PHASE1
-
Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?
NCT00578760 ·Status: UNKNOWN ·Phase: NA
-
Prevalence and Profile of Aspirin Resistance in Hemodialysis Patients
NCT00792272 ·Status: COMPLETED
-
Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin
NCT03424408 ·Status: COMPLETED ·Phase: NA
-
Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.
NCT00425074 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia
NCT01104441 ·Status: COMPLETED
-
Duration of Platelet Inhibition by Aspirin
NCT00671021 ·Status: COMPLETED
-
Multiple Daily Doses of Aspirin to Overcome Hyporesponsiveness Post Cardiac Bypass Surgery (ASACABG)- Part B
NCT01902498 ·Status: COMPLETED ·Phase: PHASE2